ENFUEL Trademark
Trademark Overview
On Wednesday, July 6, 2022, a trademark application was filed for ENFUEL with the United States Patent and Trademark Office. The USPTO has given the ENFUEL trademark a serial number of 97491217. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 2, 2024. This trademark is owned by GentiBio, Inc.. The ENFUEL trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
General Information
| Serial Number | 97491217 |
| Word Mark | ENFUEL |
| Filing Date | Wednesday, July 6, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, July 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 9, 2023 |
Trademark Statements
| Goods and Services | Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells |
| Goods and Services | Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders |
| Pseudo Mark | EN FUEL |
| Goods and Services | Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 3, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | GentiBio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
| Party Name | GentiBio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
Trademark Events
| Event Date | Event Description |
| Saturday, July 9, 2022 | NEW APPLICATION ENTERED |
| Monday, July 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, April 2, 2023 | ASSIGNED TO EXAMINER |
| Monday, April 3, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, April 3, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 3, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, April 3, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 9, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 9, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 4, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 4, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 4, 2024 | SOU EXTENSION 1 FILED |
| Thursday, January 4, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, January 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 3, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, July 3, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, July 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 20, 2024 | SOU TEAS EXTENSION RECEIVED |
